11/12/2024
6:38 PM | DG Capital Management, LLC (Filed by)
Fennec Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/08/2024
3:46 PM | Fennec Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/04/2024
4:30 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/04/2024
4:30 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
6:00 AM | Fennec Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2024
4:14 PM | Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
4:11 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
10/01/2024
4:13 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
4:02 PM | Fennec Pharmaceuticals (Subject)
Haigh Adrian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/04/2024
5:33 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
5:48 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2024
4:30 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4/A | |
08/26/2024
4:51 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
5:59 PM | Fennec Pharmaceuticals (Issuer)
Hackman Jeffrey S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
6:00 PM | Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
6:00 PM | Brughera Marco Maria (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
6:01 PM | Cook Jodi A (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
6:02 PM | Fennec Pharmaceuticals (Issuer)
Islam Khalid (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
5:56 PM | Fennec Pharmaceuticals (Issuer)
Hackman Jeffrey S. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/13/2024
4:10 PM | Fennec Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2024
3:30 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
3:21 PM | Fennec Pharmaceuticals (Subject)
Raykov Rosty (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/02/2024
4:55 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
4:42 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:43 PM | DG Capital Management, LLC (Filed by)
Fennec Pharmaceuticals (Subject)
| Form SC 13G | |
06/03/2024
5:21 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
4:12 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
4:05 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
4:05 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
4:05 PM | Fennec Pharmaceuticals (Issuer)
Haigh Adrian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
4:24 PM | Fennec Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/13/2024
3:42 PM | Fennec Pharmaceuticals (Filer)
| Form DEF 14A | |
05/02/2024
3:59 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/26/2024
3:15 PM | Fennec Pharmaceuticals (Issuer)
Haigh Adrian (Reporting)
| Form 4/A | |
04/22/2024
6:34 PM | Fennec Pharmaceuticals (Issuer)
Haigh Adrian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2024
3:21 PM | Fennec Pharmaceuticals (Subject)
Haigh Adrian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/18/2024
8:43 PM | Fennec Pharmaceuticals (Issuer)
Haigh Adrian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2024
3:24 PM | Fennec Pharmaceuticals (Subject)
Haigh Adrian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/17/2024
3:23 PM | Fennec Pharmaceuticals (Subject)
Haigh Adrian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/16/2024
5:00 PM | Fennec Pharmaceuticals (Issuer)
Haigh Adrian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2024
3:15 PM | Fennec Pharmaceuticals (Subject)
Haigh Adrian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Top "Sleeping Giant" Crypto In The Market Now (Ad) Top "Sleeping Giant" Crypto In The Market Now
We're looking at potential returns that could rewrite your financial future.
 Click here to discover our #1 crypto pick before it's too late |
04/15/2024
5:15 PM | Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2024
3:28 PM | Fennec Pharmaceuticals (Subject)
Haigh Adrian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/05/2024
3:19 PM | Fennec Pharmaceuticals (Subject)
Raykov Rosty (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024
3:46 PM | Fennec Pharmaceuticals (Subject)
Raykov Rosty (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/03/2024
4:37 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
3:55 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
4:00 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2024
3:14 PM | Fennec Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/27/2024
3:22 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
3:24 PM | Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
RALLIS CHRIS A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
3:43 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/25/2024
6:31 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
3:05 PM | Fennec Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2024
2:53 PM | Fennec Pharmaceuticals (Filer)
| Form 424B7 | |
01/05/2024
4:24 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
3:45 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024
3:42 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/29/2023
3:30 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
2:51 PM | Fennec Pharmaceuticals (Subject)
Raykov Rosty (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/17/2023
11:15 PM | Fennec Pharmaceuticals (Filer)
| Form EFFECT | |
12/05/2023
7:51 PM | Fennec Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2023
8:20 PM | Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
